| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 669790 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 669791 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 665883 | 10645002 | BRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION | BRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10645002/10645002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10645002/10645002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41367 | ADVANZ PHARMA SPAIN S.L.U. | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2010-10-19 | 1 | 2012-02-27 | View Edit Delete | ||||||||||||
| 665787 | 08479001 | ZYPADHERA 210 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 210 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 210 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479001/08479001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479001/08479001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | LABORATORIOS RUBIO S.A. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665788 | 08479002 | ZYPADHERA 300 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 300 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 300 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479002/08479002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479002/08479002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | LABORATORIOS RUBIO S.A. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665789 | 08479003 | ZYPADHERA 405 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 405 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 405 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479003/08479003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479003/08479003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | LABORATORIOS RUBIO S.A. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665906 | 07420002 | CYANOKIT 5 g POLVO PARA SOLUCION PARA PERFUSION | CYANOKIT 5 g POLVO PARA SOLUCION PARA PERFUSION, 1 vial | 5.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07420002/07420002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07420002/07420002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16769 | LABORATORIOS RUBIO S.A. | 2010-11-19 | 1 | 1 | 1 | 2010-11-19 | 2010-11-19 | 0 | 2012-01-04 | View Edit Delete | ||||||||||||
| 668830 | 61670 | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL , 1 envase pulverizador de 200 dosis | 100 microgramos/dosis | 45 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61670/61670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61670/61670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 670502 | 72349 | BREVIBLOC 10 mg/ml SOLUCION INYECTABLE | BREVIBLOC 10 mg/ml SOLUCION INYECTABLE , 5 viales de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 5 | 34 | 5 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72349/72349_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72349/72349_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2011-07-21 | 1 | 1 | 1 | 2011-07-21 | 2011-07-21 | 1 | 2012-09-05 | View Edit Delete | ||||||||||||
| 667193 | 71868 | FLUOROURACILO ACCORD 50 mg/ml SOLUCION INYECTABLE O PARA PERFUSION EFG | FLUOROURACILO ACCORD 50 mg/ml SOLUCION INYECTABLE O PARA PERFUSION EFG, 1 vial de 5 ml | 50 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71868/71868_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71868/71868_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-12-01 | 1 | 1 | 1 | 2010-12-01 | 2010-12-01 | 1 | 2011-06-02 | View Edit Delete | ||||||||||||
| 667895 | 70707 | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml | 10 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70707/70707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70707/70707_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 0 | 2012-02-23 | View Edit Delete | ||||||||||||
| 667896 | 70707 | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 10 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70707/70707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70707/70707_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 0 | 2012-02-06 | View Edit Delete | ||||||||||||
| 667897 | 70707 | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 45 ml | 10 mg/ml inyectable 45 ml | 45 | 1 | 34 | 1 vial de 45 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70707/70707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70707/70707_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 0 | 2012-02-06 | View Edit Delete | ||||||||||||
| 670696 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2010-10-01 | 1 | 2011-03-03 | View Edit Delete | ||||||||||||
| 670697 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2010-10-01 | 1 | 2011-03-03 | View Edit Delete | ||||||||||||
| 665780 | 08502001 | MEPACT 4 mg POLVO PARA SUSPENSION PARA PERFUSION | MEPACT 4 mg POLVO PARA SUSPENSION PARA PERFUSION, 1 vial | 4 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08502001/08502001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08502001/08502001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2011-03-01 | View Edit Delete | ||||||||||||
| 665953 | 05318002 | REVATIO 0,8 MG/ML SOLUCION INYECTABLE | REVATIO 0,8 MG/ML SOLUCION INYECTABLE, 1 vial de 12,5 ml | 0,8 mg/ml inyectable 12,5 ml | 45 | 1 | 34 | 1 vial de 12,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05318002/05318002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05318002/05318002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 33758 | VIATRIS PHARMACEUTICALS S.L. | 2011-03-10 | 1 | 1 | 1 | 2011-03-10 | 2011-03-10 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 665881 | 10646002 | VPRIV 400 UNIDADES POLVO PARA SOLUCION PARA PERFUSION | VPRIV 400 UNIDADES POLVO PARA SOLUCION PARA PERFUSION, 1 vial | 400 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10646002/10646002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10646002/10646002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2010-10-28 | 1 | 1 | 1 | 2010-10-28 | 2010-10-28 | 1 | 2011-05-19 | View Edit Delete | ||||||||||||
| 667541 | 70642 | ZOMACTON 10 mg/ ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ZOMACTON 10 mg/ ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 10 mg | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70642/70642_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70642/70642_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 2010-03-23 | 1 | 1 | 1 | 2010-03-23 | 2010-03-23 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 666610 | 62635 | CEFTRIAXONA NORMON 1000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG | CEFTRIAXONA NORMON 1000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG, 1 vial + 1 ampolla de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62635/62635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62635/62635_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 0 | 2011-10-20 | View Edit Delete |
Page 245 of 1036, showing 20 records out of 20709 total, starting on record 4881, ending on 4900